The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...

The Cell & Gene Meeting on the Med brings together the ATMP community from Europe and beyond and covers a wide range of ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Set in one of Europe's fastest-growing biotech hubs, Advanced Therapies Europe will welcome decision-makers from biotech and ...

The US Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced neuroendocrine tumors.

Researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the Department ...

New treatment for advanced blood cancer recommended for use on NHS - It is estimated that about 800 people with Hodgkin ...

Rapid advances in heart failure therapies over the past couple of decades mean that Stage D heart failure is no longer a ...

Precise questions, for the present and the future of the Oncological radiotherapy. In front of the institutions, they are the ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.